ストックスクリーナーアプリを入手
16.35
2.10%
-0.35
アフターアワーズ：
16.37
0.02
+0.12%
前日終値:
$16.70
開ける：
$16.52
24時間の取引高:
1.21M
Relative Volume:
1.16
時価総額：
$985.69M
収益：
$434.53M
当期純損益:
$-42.72M
株価収益率:
-22.09
EPS:
-0.74
ネットキャッシュフロー:
$21.88M
1週間 パフォーマンス:
+5.96%
1か月 パフォーマンス:
-24.90%
6か月 パフォーマンス:
-36.85%
1年 パフォーマンス:
-36.23%
1日の値動き範囲:
$16.09
$16.90
1週間の範囲:
$15.46
$17.18
52週間の値動き範囲:
$15.41
$32.76
Phreesia Inc Stock (PHR) Company Profile
PHR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHR
Phreesia Inc
|
16.35 | 1.01B | 434.53M | -42.72M | 21.88M | -0.74 |
|
VEEV
Veeva Systems Inc
|
219.30 | 36.18B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.11 | 12.22B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.80 | 8.41B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
96.00 | 8.18B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
36.44 | 6.49B | 11.99B | 24.18M | 234.31M | 0.2956 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-09-05 | 再開されました | DA Davidson | Buy |
| 2025-08-27 | 開始されました | Mizuho | Outperform |
| 2025-01-08 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-26 | 開始されました | Truist | Buy |
| 2024-01-17 | アップグレード | DA Davidson | Neutral → Buy |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-04-12 | 開始されました | Stephens | Overweight |
| 2023-01-04 | 繰り返されました | Needham | Buy |
| 2022-12-13 | アップグレード | Citigroup | Neutral → Buy |
| 2022-12-09 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-13 | 開始されました | DA Davidson | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-01-06 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-09-02 | 繰り返されました | Needham | Buy |
| 2021-08-27 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-13 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-06-08 | 開始されました | Berenberg | Buy |
| 2021-04-29 | 再開されました | JP Morgan | Overweight |
| 2021-04-01 | 開始されました | Robert W. Baird | Outperform |
| 2020-11-11 | 開始されました | Stephens | Overweight |
| 2020-10-27 | 開始されました | Needham | Buy |
| 2020-09-22 | 開始されました | DA Davidson | Buy |
| 2020-07-14 | 開始されました | Citigroup | Neutral |
| 2020-05-15 | 開始されました | Guggenheim | Buy |
| 2020-04-21 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-04-13 | 開始されました | SVB Leerink | Outperform |
| 2020-01-31 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-01-09 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-12-20 | 開始されました | Raymond James | Outperform |
| 2019-10-11 | 開始されました | Robert W. Baird | Outperform |
| 2019-08-13 | 開始されました | JP Morgan | Overweight |
| 2019-08-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-08-12 | 開始されました | Wells Fargo | Outperform |
| 2019-08-12 | 開始されました | William Blair | Outperform |
| 2019-07-23 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Phreesia Inc (PHR) 最新ニュース
Phreesia (PHR) Receives Updated Price Target from Barclays | PHR Stock News - GuruFocus
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying By Investing.com - Investing.com Nigeria
Piper Sandler sees Doximity and Phreesia as oversold, recommends buying - Investing.com
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event - Investing.com
Phreesia (PHR) analyst model updated to reflect company’s latest financial guidance for 2026-2027 - MSN
Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027 - Insider Monkey
Phreesia Executive Earns National Spotlight on MM+M’s 2025 40 Under 40 - MyChesCo
Phreesia (PHR) Is Down 19.9% After Profit Turnaround And Higher Revenue OutlookHas The Bull Case Changed? - simplywall.st
Phreesia (PHR) Is Down 19.9% After Profit Turnaround But Soft Revenue OutlookWhat's Changed - Yahoo Finance
Phreesia (PHR) loses 32.2% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Why Phreesia stock plummeted by 23% today - MSN
Phreesia outlines $545M–$559M fiscal 2027 revenue target as AccessOne acquisition expands provider financing and HCP marketing reach - MSN
Phreesia stock price target lowered to $25 at Raymond James on guidance cut - Investing.com Australia
Truist Cuts Price Target on Phreesia to $29 From $36, Keeps Buy Rating - marketscreener.com
Marshall Wace LLP Has $11.91 Million Stock Holdings in Phreesia, Inc. $PHR - MarketBeat
Phreesia stock price target lowered to $25 at Raymond James on guidance cut By Investing.com - Investing.com South Africa
Phreesia adjusts fiscal 2026 revenue outlook; introduces FY27 guidance - MSN
Phreesia (NYSE:PHR) Sees Strong Trading VolumeHere's Why - MarketBeat
PHR Analyst Ratings Update: Mizuho Lowers Price Target | PHR Sto - GuruFocus
Mizuho Lowers Phreesia (NYSE:PHR) Price Target to $28.00 - MarketBeat
Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Your Wyoming Link
MercyOne partners with Phreesia to automate social needs screenings - Business Record
Robert W. Baird Cuts Phreesia (NYSE:PHR) Price Target to $25.00 - MarketBeat
PHR Stock: Baird Lowers Price Target, Maintains Outperform Ratin - GuruFocus
Barclays Initiates Coverage on Phreesia (NYSE:PHR) - MarketBeat
Phreesia (NYSE:PHR) Upgraded at Zacks Research - MarketBeat
Phreesia stock hits 52-week low at $18.17 amid market challenges - Investing.com Canada
Citizens reiterates Market Outperform rating on Phreesia stock at $34 By Investing.com - Investing.com Australia
Why Phreesia Stock Plummeted by 23% Today - Yahoo Finance
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns - Investing.com Nigeria
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns By Investing.com - Investing.com South Africa
Phreesia, Inc. SEC 10-Q Report - TradingView — Track All Markets
PHR: Citigroup Lowers Price Target While Maintaining Buy Rating - GuruFocus
Citigroup Issues Pessimistic Forecast for Phreesia (NYSE:PHR) Stock Price - MarketBeat
Is Phreesia a Hidden Opportunity After Recent Digital Patient Intake Partnerships? - Yahoo Finance
JPMorgan Chase & Co. Cuts Phreesia (NYSE:PHR) Price Target to $29.00 - MarketBeat
Needham Reiterates Buy Rating for Phreesia (PHR) with $35 Price Target | PHR Stock News - GuruFocus
Canaccord Genuity Lowers Price Target for Phreesia (PHR) | PHR S - GuruFocus
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook - Investing.com Nigeria
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook By Investing.com - Investing.com South Africa
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target - Investing.com Nigeria
Phreesia (PHR) Gains Momentum with New "Overweight" Rating by Ba - GuruFocus
Phreesia (NYSE:PHR) Reaches New 52-Week LowHere's Why - MarketBeat
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target By Investing.com - Investing.com South Africa
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech
Phreesia stock hits 52-week low at $18.17 amid market challenges By Investing.com - Investing.com South Africa
Phreesia Posts Solid Earnings But Shares Drop Anyway - Yahoo Finance
Phreesia, Inc. (NYSE:PHR) Q3 2026 earnings call transcript - MSN
Phreesia, Inc. (NYSE:PHR) Q3 2026 Earnings Call Transcript - Insider Monkey
Citizens reiterates Market Outperform rating on Phreesia stock at $34 - Investing.com
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say - sharewise.com
Phreesia Inc (PHR) 財務データ
収益
当期純利益
現金流量
EPS
3.40%
2.18%
大文字化:
|
ボリューム (24 時間):